OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?
Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

Form 8.3 – Aqua Acquisition Sub LLC (subsidiary of Qualcomm Incorporated)

Form 8.3 – Aqua Acquisition Sub LLC (subsidiary of Qualcomm Incorporated)

Earnings To Watch: Nvidia (NVDA) Reports Q2 Results Tomorrow

Earnings To Watch: Nvidia (NVDA) Reports Q2 Results Tomorrow

Fox channels may go dark on YouTube TV from Wednesday over payment dispute

Fox channels may go dark on YouTube TV from Wednesday over payment dispute

Inside Elon Musk’s suit against Apple and OpenAI: ‘This is a tale of two monopolists’

Inside Elon Musk’s suit against Apple and OpenAI: ‘This is a tale of two monopolists’

What’s Going On With AMD Stock Monday?

What’s Going On With AMD Stock Monday?

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds

Uruguay Senate Approves New Bill To Regulate Access To Medical Cannabis

December 10, 2019

To help put a definitive end to persisting illicit cannabis markets, Uruguay's senate has passed a new bill to regulate medical marijuana. The bill, "A...

3rdPartyFeeds • News

In One Chart: Why President Trump’s constant cheerleading of the stock market might not help him much come election time

December 10, 2019

A recent poll of likely voters shows 61% of Americans said that the market’s rally has had little or no impact on their finances.

Read More...

3rdPartyFeeds

UPDATE 2-Thousands of UK political ads went missing from Facebook archive searches

December 10, 2019

Thousands of UK political ads went missing from Facebook Inc's searchable advertising database on Tuesday, hampering researchers' ability to track ads two days...

3rdPartyFeeds

UPDATE 1-Thousands of UK political ads missing from Facebook archive searches

December 10, 2019

Thousands of UK political ads went missing from Facebook's searchable advertising database on Tuesday, hampering researchers' ability to track political ads...

3rdPartyFeeds • News

Need to Know: There’s no better place to put your money than in the U.S., says hedge-fund manager Kyle Bass

December 10, 2019

Investors are looking rattled on Tuesday as that U.S.-China trade deadline nears. Our call of the day from hedge fund manager Kyle Bass, says: “Don’t bet...

3rdPartyFeeds • News

MarketWatch First Take: What Amazon is really accusing Trump of doing in JEDI deal

December 10, 2019

The conspiracy theory at the heart of Amazon.com Inc.’s lawsuit over its loss of the $10 billion JEDI contract is another example of more possibly unethical...

3rdPartyFeeds

What Amazon is really accusing Trump of doing in JEDI deal

December 10, 2019

The conspiracy theory at the heart of Amazon.com Inc.’s lawsuit over its loss of the $10 billion JEDI contract is another example of more possibly unethical...

3rdPartyFeeds

Peru plans taxing Netflix, Uber and digital businesses: official

December 10, 2019

Read More...

3rdPartyFeeds

Take Two (TTWO) Launches Cloud Chamber, New Bioshock in Development

December 10, 2019

Take-Two Interactive (TTWO) announces the launch of new studio to expand portfolio and push the boundaries of interactive entertainment. Read More...

3rdPartyFeeds

U.S. attorney general says Big Tech probes to be completed next year

December 10, 2019

U.S. Attorney General William Barr said on Tuesday that he hoped to have Justice Department investigations of the big tech platforms - Facebook Inc, Alphabet...

Previous 1 … 7,046 7,047 7,048 7,049 7,050 … 8,351 Next
Indices by TradingView
Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

August 26, 2025
Form 8.3 – Aqua Acquisition Sub LLC (subsidiary of Qualcomm Incorporated)

Form 8.3 – Aqua Acquisition Sub LLC (subsidiary of Qualcomm Incorporated)

August 26, 2025
Earnings To Watch: Nvidia (NVDA) Reports Q2 Results Tomorrow

Earnings To Watch: Nvidia (NVDA) Reports Q2 Results Tomorrow

August 25, 2025
Fox channels may go dark on YouTube TV from Wednesday over payment dispute

Fox channels may go dark on YouTube TV from Wednesday over payment dispute

August 25, 2025
Inside Elon Musk’s suit against Apple and OpenAI: ‘This is a tale of two monopolists’

Inside Elon Musk’s suit against Apple and OpenAI: ‘This is a tale of two monopolists’

August 25, 2025

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.